Form 4: Milestone Scientific Director Leonard Osser Acquires Shares as Part of Annual Fee
SEC Form 4 Filing
Director Leonard Osser acquired 112,356 shares of Milestone Scientific Inc. common stock on August 28, 2024, as part of his annual director's fee.
Summary
- On August 28, 2024, Leonard Osser, a director of Milestone Scientific Inc., acquired 112,356 shares of common stock at a price of $0.89 per share.
- This acquisition was part of the annual fee paid to non-employee directors, totaling $100,000, payable in restricted shares.
- The shares vest over time, with one-fourth vesting immediately upon grant and the remaining balance vesting in equal tranches on October 1, 2024, January 1, 2025, and April 1, 2025.
- Following the transaction, Osser directly owns 4,714,862 shares of Milestone Scientific Inc.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. The director is increasing their stake in the company, which can be seen as a positive sign. The acquisition is part of a pre-determined compensation plan, so it's not necessarily a strong indicator of future performance, but it does show alignment of interests.
Positives
- Director's commitment to the company is demonstrated through equity ownership.
- The vesting schedule incentivizes long-term alignment with company performance.
Industry Context
Director compensation in the form of equity is a common practice to align the interests of board members with those of shareholders. The vesting schedule encourages long-term commitment.
Comparison to Industry Standards
- Equity compensation for board members is a common practice across various industries.
- Companies like Dentsply Sirona and Align Technology also use stock options and restricted stock units as part of their director compensation packages.
- The specific amount and vesting schedule can vary based on company size, industry, and individual director roles.
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive sign of commitment.
- Employees may see this as a sign of confidence in the company's future.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Date of transaction: Leonard Osser acquired 112,356 shares of Milestone Scientific Inc. |
| 10/01/2024 | First vesting tranche of the restricted shares. |
| 01/01/2025 | Second vesting tranche of the restricted shares. |
| 04/01/2025 | Third vesting tranche of the restricted shares. |
| 08/30/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.